Koers Sigilon Therapeutics, Inc.
Aandelen
SGTX
US82657L2060
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 60 | 14-08-18 | |
Director of Finance/CFO | 58 | 01-11-19 | |
Philip Johnson
PSD | President | 59 | 11-08-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 60 | 14-08-18 | |
Philip Johnson
PSD | President | 59 | 11-08-23 |
Gordon Brooks
BRD | Director/Board Member | - | 11-08-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,78% | 41,36 mld. | |
+45,26% | 41,3 mld. | |
+4,01% | 39,61 mld. | |
-15,14% | 25,62 mld. | |
+3,16% | 24,09 mld. | |
-24,08% | 18,38 mld. | |
-2,67% | 11,82 mld. | |
+24,76% | 11,85 mld. | |
+7,01% | 11,07 mld. |